PID

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change +0.06
Percentage change 0.33	%

Category	Global or ExUS Equities - Dividend & Fundamental	Asset Type	Equities (Stocks)	Tags	International	Return% 1Y	3.02%	Shs Outstand		Perf Week	-2.03%
Sponsor	Invesco	ETF Type		Tags	equity	Return% 3Y	4.46%	Total Holdings	48	Perf Month	-4.88%
Fund Family		Bond Type		Tags	dividend	Return% 5Y	5.15%	AUM	810.65M	Perf Quarter	-6.62%
Index	NASDAQ Intl Div Achievers Indx	Average Maturity		Tags	-	Return% 10Y		NAV%		Perf Half Y	3.09%
Index Weighting		Commodity Type		Tags	-	Return% SI		NAV/sh		Perf Year	-0.35%
Active/Passive		Quant Type		Tags	-	Flows% 1M	-0.28%	52W Range	17.28 - 19.99	Perf YTD	-0.64%
Dividend TTM	0.71 (3.87%)	ESG Type		Tags	-	Flows% 3M	-1.10%	52W High	-8.25%	Beta	0.97
Dividend Ex-Date	Dec 23, 2024	Dividend Type		Sector/Theme		Flows% YTD	-18.54%	52W Low	6.11%	ATR (14)	0.21
Expense	0.53%	Structure Type		Region		Flows% 1Y		RSI (14)	31.26	Volatility	1.58% 1.05%
Option/Short	Yes / Yes	Growth/Value		Dev/Emerg		Flows% 3Y		Rel Volume	2.29	Prev Close	18.28
Inverse/Leveraged		Market Cap		Currency		Flows% 5Y		Avg Volume	79.87K	Price	18.34
SMA20	-3.32%	SMA50	-4.43%	SMA200	-2.48%	Trades		Volume	179,762	Change	0.33%

Aug-11-21 06:41PM	BAM Option Traders Banking on Earnings Rise (Investopedia)
Feb-07-20 02:30PM	Is Recession Knocking at the Door? ETF Strategies to Follow (Zacks)
Jan-21-20 08:33AM	Economic Slowdown in 2020? ETF Strategies to Help You (Zacks)
Aug-16-19 08:00AM	5 High-Dividend ETFs Available Under $20 (Zacks)
Apr-16-19 08:00AM	4 ETF Strategies to Follow Amid Global Growth Slowdown (Zacks)
11:03AM	Loading…
Mar-06-18 11:03AM	7 Intelligent International Dividend ETFs for Blue-Chip Income (InvestorPlace)
Feb-06-18 08:10AM	Dividend plays on slippery ground as bond yields steepen (Reuters)
Jan-26-18 07:30AM	How Is Novartiss Subsidiary Sandoz Positioned for 2018? (Market Realist)
Jan-22-18 11:30AM	Behind Novartiss 4Q17 Estimates: Innovative Medicines (Market Realist)
Nov-14-17 01:05PM	Behind Sanofis 3Q17 Revenue Growth (Market Realist)
Sep-14-17 09:19AM	The Zacks Analyst Blog Highlights: SDIV, DWX, LVL, FGD and PID (Zacks)
09:07AM	How TEVAs CNS Drugs Performed in 1H17 (Market Realist)
Sep-13-17 01:27PM	5 Hot Global Dividend ETFs (Zacks)
10:37AM	How TEVAs Generic Medicines Franchise Is Positioned after 1H17 (Market Realist)
Sep-11-17 12:32PM	How ONEOK Has Managed Its Impressive Dividend Yield (Market Realist)
06:06PM	Loading…
Aug-30-17 06:06PM	What Happened to Novartiss Innovative Medicines Business in 2Q17? (Market Realist)
02:11PM	Global Dividend Payments Upbeat in Q2: ETFs to Benefit (Zacks)
Aug-23-17 12:42PM	Dividend Yield of Stanley Black & Decker (Market Realist)
Aug-18-17 10:37AM	A Look at Sanofi Pasteurs Performance in 2Q17 (Market Realist)
07:37AM	North America: Fresenius Medical Cares Major Target Market in 2017 (Market Realist)
Aug-17-17 09:07AM	Sanofi Genzyme Continues Driving Revenue Growth in 2Q17 (Market Realist)
Aug-16-17 09:32AM	Kimberly-Clarks Dividend Growth (Market Realist)
Jul-25-17 07:39AM	Novartis in 2Q17: Performance of Sandoz (Market Realist)
Jul-17-17 12:05PM	Analysts Expect Novartiss Revenues to Fall in 2Q17 (Market Realist)
Jun-13-17 10:36AM	What Makes This Global Dividend Income ETF So Popular (Zacks)
Jun-01-17 09:09AM	Inside Novartiss Segment-Wise Performance in 1Q17 (Market Realist)
May-29-17 09:06AM	Performance of Sanofis Established Prescription Products in 1Q17 (Market Realist)
May-02-17 12:00PM	Don't Sell, Buy 4 High Dividend ETFs Under $20 in May (Zacks)
09:07AM	How GlaxoSmithKlines Vaccines Business Performed in 1Q17 (Market Realist)
May-01-17 07:40AM	How GlaxoSmithKlines Business Segments Performed in 1Q17 (Market Realist)
05:05PM	Loading…
Apr-27-17 05:05PM	Novartiss 1Q17 Earnings: Innovative Medicines Segment (Market Realist)
Apr-26-17 07:36AM	GlaxoSmithKlines 1Q17 Estimates: Vaccines Business (Market Realist)
Apr-24-17 10:37AM	Analyst Ratings and Recommendations for Novartis (Market Realist)
Apr-21-17 01:13PM	Analyst Estimates for Novartiss 1Q17 Earnings (Market Realist)
Apr-04-17 07:36AM	Novartis Expects to Restore Alcons Profitability in the Future (Market Realist)
Apr-03-17 07:37AM	Sanofi Genzyme Continued Growth in 2016 (Market Realist)
Mar-30-17 10:36AM	Reduced Co-pays May Boost Demand for Entresto (Market Realist)
07:36AM	Performance of GlaxoSmithKlines Vaccines Business in 2016 (Market Realist)
Mar-29-17 07:37AM	GlaxoSmithKlines Pharmaceuticals Segment Performance (Market Realist)
Mar-28-17 02:56PM	With low yields abroad, investors hunt for international dividend funds (MarketWatch)
Mar-27-17 10:37AM	Sandoz: Novartiss Generics Business in 2016 (Market Realist)
09:08AM	Novartiss Innovative Medicines Segment in 2016 (Market Realist)
Feb-21-17 10:36AM	What Happened to Sanofis Valuation after 4Q16? (Market Realist)
Feb-20-17 07:37AM	This Keeps Driving Sanofis Growth
Feb-16-17 07:35AM	GlaxoSmithKlines Consumer Healthcare Reports Growth in 4Q16
Feb-15-17 10:36AM	GlaxoSmithKlines Vaccines Business Reported Growth in 4Q16
Feb-14-17 01:35PM	4Q16 Performance of GlaxoSmithKlines Business Segments
Feb-01-17 04:35PM	Novartiss Innovative Medicines Segment in 4Q16
Jan-30-17 10:36AM	PotashCorp in 4Q16: Nitrogen Prices Added Salt to the Wound
Jan-23-17 09:07AM	Novartiss 4Q16 Estimates: Innovative Medicines Segment
Jan-17-17 09:06AM	How Did Novartiss Generics Business Perform in 3Q16?
Dec-30-16 09:07AM	How GlaxoSmithKlines Pharmaceuticals Segment Has Performed
Dec-14-16 09:30AM	The Zacks Analyst Blog Highlights: Guggenheim S&P Global Dividend Opportunities Index ETF, PowerShares International Dividend Achievers Portfolio, PowerShares High Yield Equity Dividend Achievers Portfolio and AdvisorShares Athena High Divi
Dec-13-16 11:05AM	4 High Dividend ETFs Under $20
Nov-23-16 04:01PM	PowerShares Announces Listing Transfer for 27 ETFs (PR Newswire)
Nov-17-16 11:04AM	How Sandoz Performed for Novartis in 3Q16
Nov-03-16 10:04AM	How Tresiba Helps Novo Achieve Its Growth Targets
08:04AM	Victoza Dominates Global GLP-1 Class
Nov-02-16 11:04AM	Reading Novos Insulin Portfolio to Find Clues about Its Growth
Nov-01-16 06:04PM	US Still the Largest Market for Novo Nordisk
08:04AM	Why Did PotashCorps Nitrogen Prices Fall in 3Q16?
Oct-25-16 10:52AM	How Much Is the Return Opportunity for Novo Nordisk in 3Q16?
Oct-24-16 11:04AM	Novartiss 3Q16 Estimates: Will Alcon Recover Its Growth?
08:05AM	Novartiss 3Q16 Estimates: Innovative Medicines Segment
Oct-20-16 09:44AM	5 Best Smart Beta ETFs That Pay Dividends (PID, ICF) (Investopedia)
Oct-07-16 01:16PM	Is the Dividend ETF Bull Run Over?
Oct-06-16 09:00AM	International Dividend ETFs Remain Solid Ideas
Oct-03-16 10:04AM	Novo Nordisk Expects to Witness Strong Growth from New Product Launches
Sep-30-16 06:04PM	Novo Nordisk Is Expected to See Strong Growth in Insulin Segment
Sep-29-16 05:04PM	Novo Nordisk Is Focusing on These Strategic Areas in 2016
Sep-28-16 11:04AM	Tevas Share of the US Generics Market Could Boost Its Stock
Sep-26-16 11:05AM	Winning? We Review How Teva Dominates Generic Drug Space
Sep-15-16 11:04AM	Sanofis Chase for Zika Virus Vaccine Could Drive Its Share Price
08:04AM	Will Sanofi See More Growth from Its Blockbuster Insulin Drug?
Sep-13-16 11:04AM	GSK Optimistic about Future of Its Consumer Healthcare Segment
10:04AM	GlaxoSmithKline Giving a Shot to Its Vaccines Business
Sep-12-16 11:04AM	GlaxoSmithKlines Combo Treatment for HIV Faces Stiff Competition
Sep-08-16 12:27PM	5 Undervalued ETFs for Dividend Lovers
11:18AM	Analyzing Sanofis Asset Swap Deal with Boehringer Ingelheim
Aug-22-16 11:04AM	Teva Pharmaceutical: A Successful Bond Financing Program in 2016
11:04AM	How Merial Contributes to Sanofis Growth
Aug-19-16 11:04AM	What Happened to Sanofis Consumer Healthcare and Generics Franchise in 2Q16?
Aug-18-16 11:04AM	Behind Sanofis Diabetes and Cardiovascular Performance in 2Q16
09:06AM	Genzyme Continued to Boost Growth for Sanofi in 2Q16
Aug-17-16 05:05PM	Inside Sanofis Valuation Changes
Aug-09-16 03:40PM	How Did Novo Nordisk Perform across Geographies in 1H16?
Aug-08-16 10:09AM	A New Low Volatility International ETF for Dividend Lovers
10:09AM	A New Low Volatile International ETF for Dividend Lovers
Aug-05-16 11:07AM	An Update on Shires Upcoming Milestones
Aug-02-16 09:07AM	How Did GlaxoSmithKlines Pharmaceuticals Segment Do in 2Q16?
Aug-01-16 04:47PM	How Much Growth Will Novo See in 2Q16?
Jul-30-16 08:40PM	GlaxoSmithKline Increases Top Line in 2Q16

Invesco International Dividend Achievers ETF seeks to track the investment results (before fees and expenses) of the NASDAQ International Dividend AchieversTM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of Global Depositary Receipts ("GDRs") that are listed on the London Stock Exchange ("LSE") or the London International Exchange, American Depositary Receipts ("ADRs"), non-U.S. common or ordinary stocks, limited partnership interests and shares of limited liability companies that are listed on the NYSE.

open in yahoo | open in marketwatch | open in google

Invesco International Dividend Achievers ETF

Upgrade your FINVIZ experience